USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/11924
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUrsan, Mariana-
dc.date.accessioned2020-10-05T08:54:01Z-
dc.date.available2020-10-05T08:54:01Z-
dc.date.issued2020-
dc.identifier.citationURSAN, Mariana. Mechanisms of venous thromboembolism in oral contraception. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 263.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/11924-
dc.descriptionDepartment of Biochemistry and Clinical Biochemistry, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020en_US
dc.description.abstractIntroduction. Combined oral contraceptives (COC) are more and more used by fertile women, as well as teenagers in different cases, like dysmenorrhea, endometriosis, ovarian polycystic syndrome, dysfunctional uterine bleeding (DUB) and hormone-replacement therapy (HRT) for primary ovarian insufficiency. Even if they act efficiently in pregnancy prevention and hormonal regulation, they also significantly increase the risk of venous thromboembolism. Recent researches have shown that the risk of venous thromboembolism depends a lot on the ratio of estrogen/progestin in combined oral contraceptives and on thrombotic events of women on COC. Aim of the study. Description of the mechanisms that can induce venous thromboembolism and the selection of women potentially predisposed to them. Highlighting the frequency of their occurrence depending on the ratio estrogen/progestin in the composition of combined oral contraceptive. Individual prescription for oral contraceptives, in order to reduce their risk for health. Materials and methods. The literature analysis has been conducted using 98 bibliographic sources from PubMed search engine starting with January 2017 and from PMC since January 2015. Results. In women with mutation of Factor V Leiden and prothrombin, as well as defects of antithrombin III, protein C and S, that take hormonal contraceptives, the risk of venous thromboembolism increases up to 3-9%, unlike women who do not take them. Also, women who take oral contraceptives with estrogen and levonorgestrel, deriving from progestin, have a high level of Factor VII, X and fibrinogen, produced by high hepatic synthesis stimulated by the first hepatic degradation of estrogen, and high APC resistance and low level of antithrombine and protein S. Thus, favorable conditions for venous thromboembolism occur. Conclusions. In women who take oral contraceptives the risk of thrombosis is higher than in women who do not take them. The mechanisms inducing venous thromboembolism depend a lot on the specific ratio of estrogen/progestin and the presence of hereditary or acquired thrombophilia in women on COC.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectoral contraceptivesen_US
dc.subjectvenous thromboembolismen_US
dc.subjecthormonesen_US
dc.subjectthrombophiliaen_US
dc.titleMechanisms of venous thromboembolism in oral contraceptionen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2020

Files in This Item:
File Description SizeFormat 
Ursan_Mariana.pdf299.65 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback